Factors associated with poor clinical outcomes or shorter survival in breast cancer include tumor size, tumor grade, axillary lymph node status, estrogen receptor (ER) status, progesterone receptor (PR) status, and human epidermal growth factor receptor 2 (Her2/neu) status [5, 6]. The gene discussed is PGR; the disease is breast cancer.